Perry Kennedy

544 total citations
12 papers, 429 citations indexed

About

Perry Kennedy is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Perry Kennedy has authored 12 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Cell Biology and 3 papers in Oncology. Recurrent topics in Perry Kennedy's work include Sphingolipid Metabolism and Signaling (8 papers), Cellular transport and secretion (4 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). Perry Kennedy is often cited by papers focused on Sphingolipid Metabolism and Signaling (8 papers), Cellular transport and secretion (4 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). Perry Kennedy collaborates with scholars based in United States, France and Canada. Perry Kennedy's co-authors include Kevin R. Lynch, Timothy L. Macdonald, Yugesh Kharel, Thomas P. Mathews, Harshani R. Lawrence, Muhammad Ayaz, José G. Treviño, Aslamuzzaman Kazi, Saı̈d M. Sebti and Shengyan Xiang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Biochemical Journal.

In The Last Decade

Perry Kennedy

12 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Perry Kennedy United States	10	357	97	72	50	32	12	429
Miryam Pastor Spain	8	255 0.7×	97 1.0×	53 0.7×	46 0.9×	21 0.7×	11	362
Nathalie Desban France	13	410 1.1×	100 1.0×	69 1.0×	31 0.6×	28 0.9×	18	556
Jeannene Butler United States	6	291 0.8×	117 1.2×	111 1.5×	19 0.4×	30 0.9×	8	417
Yoh Terada Japan	8	326 0.9×	136 1.4×	64 0.9×	75 1.5×	25 0.8×	15	483
Claus J. Jensen Denmark	5	478 1.3×	94 1.0×	106 1.5×	26 0.5×	34 1.1×	5	550
Andreas Theuer Switzerland	3	265 0.7×	102 1.1×	50 0.7×	23 0.5×	14 0.4×	3	306
Ellen Lorimer United States	12	368 1.0×	80 0.8×	96 1.3×	18 0.4×	15 0.5×	17	492
Alain Bruno France	9	273 0.8×	73 0.8×	60 0.8×	21 0.4×	47 1.5×	14	395
Mark Bittner United States	7	386 1.1×	214 2.2×	45 0.6×	26 0.5×	49 1.5×	12	494
Heidrun Hirner Germany	10	272 0.8×	54 0.6×	156 2.2×	37 0.7×	24 0.8×	11	407

Countries citing papers authored by Perry Kennedy

Since Specialization

Citations

This map shows the geographic impact of Perry Kennedy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Perry Kennedy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Perry Kennedy more than expected).

Fields of papers citing papers by Perry Kennedy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Perry Kennedy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Perry Kennedy. The network helps show where Perry Kennedy may publish in the future.

Co-authorship network of co-authors of Perry Kennedy

This figure shows the co-authorship network connecting the top 25 collaborators of Perry Kennedy. A scholar is included among the top collaborators of Perry Kennedy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Perry Kennedy. Perry Kennedy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Kazi, Aslamuzzaman, Vasantha Kumar M.V., Bogos Agianian, et al.. (2023). Discovery of KRB-456, a KRAS G12D Switch-I/II Allosteric Pocket Binder That Inhibits the Growth of Pancreatic Cancer Patient-derived Tumors. Cancer Research Communications. 3(12). 2623–2639. 10 indexed citations

Kazi, Aslamuzzaman, Shengyan Xiang, Hua Yang, et al.. (2019). Dual Farnesyl and Geranylgeranyl Transferase Inhibitor Thwarts Mutant KRAS-Driven Patient-Derived Pancreatic Tumors. Clinical Cancer Research. 25(19). 5984–5996. 53 indexed citations

Kazi, Aslamuzzaman, Shengyan Xiang, Hua Yang, et al.. (2018). GSK3 suppression upregulates β-catenin and c-Myc to abrogate KRas-dependent tumors. Nature Communications. 9(1). 5154–5154. 99 indexed citations

Zitomer, Nicholas C., et al.. (2012). Distinct generation, pharmacology, and distribution of sphingosine 1‐phosphate and dihydro‐sphingosine 1‐phosphate in human neural progenitor cells. The FASEB Journal. 26(S1). 8 indexed citations

Kennedy, Perry, Ran Zhu, Tao Huang, et al.. (2011). Characterization of a Sphingosine 1-Phosphate Receptor Antagonist Prodrug. Journal of Pharmacology and Experimental Therapeutics. 338(3). 879–889. 29 indexed citations

East, James E., Perry Kennedy, Nancy A. Schulte, et al.. (2011). Development of a phosphatase-resistant, l-tyrosine derived LPA1/LPA3 dual antagonist. MedChemComm. 2(4). 325–325. 9 indexed citations

Zitomer, Nicholas C., et al.. (2011). Distinct generation, pharmacology, and distribution of sphingosine 1-phosphate and dihydrosphingosine 1-phosphate in human neural progenitor cells. Neuropharmacology. 62(2). 988–996. 26 indexed citations

Kharel, Yugesh, Thomas P. Mathews, Jose L. Tomsig, et al.. (2011). Sphingosine kinase type 1 inhibition reveals rapid turnover of circulating sphingosine 1-phosphate. Biochemical Journal. 440(3). 345–353. 58 indexed citations

Mathews, Thomas P., Andrew Kennedy, Yugesh Kharel, et al.. (2010). Discovery, Biological Evaluation, and Structure−Activity Relationship of Amidine Based Sphingosine Kinase Inhibitors. Journal of Medicinal Chemistry. 53(7). 2766–2778. 55 indexed citations

10.

Foss, Frank W., Thomas P. Mathews, Yugesh Kharel, et al.. (2009). Synthesis and biological evaluation of sphingosine kinase substrates as sphingosine-1-phosphate receptor prodrugs. Bioorganic & Medicinal Chemistry. 17(16). 6123–6136. 27 indexed citations

11.

Zhu, Ran, Ashley H. Snyder, Yugesh Kharel, et al.. (2007). Asymmetric Synthesis of Conformationally Constrained Fingolimod Analogues—Discovery of an Orally Active Sphingosine 1-Phosphate Receptor Type-1 Agonist and Receptor Type-3 Antagonist. Journal of Medicinal Chemistry. 50(25). 6428–6435. 54 indexed citations

12.

Govindan, Ramaswamy, John Crowley, L. Schwartzberg, et al.. (2006). Final results of a phase II trial of bexarotene capsules as 3rd or subsequent line therapy in patients with advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 24(18_suppl). 7099–7099. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact